Lp,s are doomed!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
As of any product, the proof is in the pudding.
It has saved my life and i,m forever grateful.
Oncologist were giving me 1 year to prepare for my exit.
That was in 2001...
More of the same D.E.A. B.S.
Public Interest
Michigan wants to be a leader in marijuana education, but the feds stand in the way
Updated: Mar. 14, 2022, 3:04 p.m.
Lake Superior State University cannabis chemistry program
By Bonno
Michigan college students can learn about marijuana in classrooms and labs, they just can’t touch it
The Michigan Marijuana Regulatory Agency (MRA), as well as market insiders and universities, want students to learn about marijuana chemistry and horticulture so they can join and improve the state’s legal $2 billion industry, but the federal government remains in the way.
Marijuana is legal in Michigan, as well as 30-plus other states (at least for medical use), yet the federal government still classifies it as a banned and illegal schedule 1 substance. Since universities accept federal money, they’re hesitant to implement courses, degrees or certificates focused on marijuana.
“If a university was working with regulated material -- so federally defined as marijuana with higher THC concentrations -- yes, there is a risk the (Drug Enforcement Agency) could come in and do bad things,” said Benjamin Southwell, an assistant Lake Superior State University chemistry professor who helped create the college’s cannabis chemistry degree program, the first of its kind in Michigan. “The industry has been blossoming across the state, it’s doing really great things, but in a strict federal law interpretation, the whole thing is illegal.”
The MRA on March 7, created a new license type that allows universities to purchase marijuana or produce their own for educational purposes. Southwell hopes it will nudge the federal government toward marijuana legalization, especially for educational purposes. Currently, he said, even with the new license type, it’s “a bit of a gray area.”
The DEA does issue permission for specific marijuana research studies by researchers, but the marijuana has to come from DEA-approved suppliers, of which there has only been one since 1968. The DEA last year indicated it would be adding more. None of them are licensed Michigan businesses.
“Any teaching institution that wants to utilize marijuana for teaching activities needs to apply with the DEA as an analytical laboratory,” according to an agency statement emailed to MLive by DEA spokesman Brian McNeal. The “DEA does have a teaching institution registration, however it is limited to Schedules II-V substances and does not authorize activities for Schedule I controlled substances.”
For more than a year, MRA Director Andrew Brisbo said he’s been thinking about how the MRA could play a role in positioning Michigan as a leader in cannabis education.
“I had a productive discussion early on with the DEA about potential for DEA registration to be issued to post-secondary schools if there was also an underlying state license,” Brisbo said. “And then they can be protected from any concerns about federal interference in their cannabis degree programs and could actually give students opportunities to touch plants and engage with products that are actually available in the market.”
The license allows schools to procure, grow, process, study and eventually destroy marijuana products, but there’s one possible hitch: the license won’t be issued without the DEA’s blessing.
“A licensee must provide proof of registration to the (DEA) before engaging in any licensed activity,” the MRA rules say.
Lake Superior State University is the only in Michigan offering a full degree in cannabis studies. Northern Michigan University offers various cannabis certificate programs and the University of Michigan in 2019 launched at least one course focused on the plant.
Since marijuana is illegal on any public university campus due to current federal law, Lake Superior State University uses a workaround: hemp.
Hemp and marijuana are the same plant, cannabis, just defined differently by regulatory agencies. Hemp is considered cannabis with less than .3% THC, the psychoactive compound that causes a high. Marijuana is everything else, but genetically, they’re the same, Southwell said.
The extent of marijuana available to Northern Michigan University students is a “speck on a slide” that’s used for chemical analysis, said university spokesman Derek Hall. He said students learn the “exact same skills” used in Michigan’s cannabis industry, but they “might use thimbleberries or whatever plants are similar.”
“The reason academic institutions lean that way is to avoid some federal pushback related mostly to financial aid,” Southwell said. “We don’t want to interfere with out students being able to receive grants and loans from the federal government.
“So we’re still not able -- and no university is currently able -- to work with marijuana without a DEA registration, so most of our program is working with cannabis that has THC concentrations below 3%. It looks exactly the same, extracts exactly the same, it just has that one chemical that is in a lower concentration.”
Lake Superior State University’s program is a three-tiered program It includes testing for contaminates, terpenes and potency, similar to the state-licensed labs, extraction techniques and growing.
“Growing is the one we’re currently working on,” Southwell said of the program that began in 2019. “We have an indoor grow facility that’s currently being renovated and we’ve done some work in our indoor greenhouse.”
Until the university can secure a DEA registration, the grow will focus on hemp. When student conducting testing come across hemp that is technically marijuana with above the allowable THC limits, it’s immediately destroyed, Southwell said.
Similarly, Northern Michigan University students learning about marijuana aren’t able to work with it.
The new license doesn’t totally clear the way for students to test products purchased from local marijuana dispensaries or grow hundreds of plants, but Southwell believes the intent of the license is an “incremental step” in that direction.
“There’s clearly a need for some science” in the marijuana industry but “the academic side is limited rather drastically by federal prohibition,” Southwell said. “This provides some legitimacy as we move forward with our federal applications.”
When and if Lake Superior State University students are given DEA permission to procure and test licensed marijuana products, they likely will, the professor said.
Students already test cannabidiol (CBD) products for potency and other characteristics and check the results against labelling. CBD is a non-high-inducing chemical that is produced from hemp and not tightly regulated.
“We have students who go to provisioning centers, gas stations or wherever CBD is sold,” Southwell said. “We can buy those now and we’re doing that.”
But it may take some action in D.C. before Michigan students will be shopping for marijuana, testing it for mold, metals or pesticides and ensuring potency labels are accurate.
Until that time, most universities are likely to play it safe.
“Related to cannabis, (Northern Michigan University) operates by the federal guidelines of the Drug Free Schools Act,” said Hall. “Any state changes are secondary to the federal.”
NEW STEPS TOWARDS ACCEPTING MEDICAL CANNABIS IN 2022
Bonno 13, 2022
The issue with medical cannabis in the past used to be accepting it, not judging those using medical cannabis, and finding relief from its use. Fortunately, no longer are people met with broad scrutiny for it. Skeptics have opened their minds, not to mention the legalization changes that have made a difference. But the real proof is (quite literally) in the cannabis-infused pudding, so keep reading for the recipe!
The fact is, medical cannabis is effective, and users would much rather consume cannabis than a harsh opioid, which could follow with other issues attached to it, like side effects or addiction. The great thing is marijuana processed for medical purposes is safe, high quality, and is trustworthy at all times. Cannabis contains more than 60 “cannabinoid” compounds similar to the cannabinoids naturally produced by the human body. These compounds help regulate many bodily functions, including pain perception. Users have found cannabis to help with more than just pain. Cannabis has demonstrated it can alleviate nausea, appetite loss, depression, and the list goes on.
Back in January, New York doctors finally received the green light to prescribe medical marijuana at their discretion. This move is a huge step towards accepting medical cannabis in 2022. That means doctors can recommend cannabis for any condition they feel cannabis can treat rather than relying on a list of specific eligible diseases or ailments. In July 2021, the state filed a bill to create provisional marijuana licensing category so that farmers could begin cultivating and selling cannabis ahead of the formal rollout of the adult-use program. The state has even gone as far as to file legislation last month to legalize psilocybin mushrooms for medical purposes and establish facilities where the psychedelic could be grown and administered to patients.
As individuals learn more about the drug’s properties and efficacy, more is continually happening to make acquiring it easier. Again, in New York, the Cannabis Control Board has permanently waived the $50 patient fee and is advancing home cultivation regulations. Also, last year, made policy changes to allow medical cannabis patients in the state to grow plants for personal use. Over here in Canada, receiving a cannabis prescription is a breeze. With your medical history, a family doctor can guide you accordingly. Not only to approve your prescription request but also to advise on the best way to take medical cannabis. The best part of medical cannabis, unlike recreational, is that it is not only safer and tax-deductible but covered by some insurers.
Grey market:
50,000 MMAR individual licenced to grow for themselves or others.
Or any dude wanting to get in the frey and overgrow the government.
Basically a free market.
It has been that way for ages all through the world.
Craft cannabis grows small batch but do not make a dollar yet.
Large LP,s are run by bean counters who cram millions of cannabis plants in Mega-Greenhouses. Crapping tons on moldy weed.
It,s very simple... if LP,s are run by incompetent and grow sub-par weed... they loose money... drop prices... they sell assets...
Consumers will allways go for the best product at best prices.
You got that right...
US Patent 6630507 The US Government's Cannabis Patent
Home Hemp Download the Handout
Bonno
Marijuana has been a Schedule I drug in the United States since the Controlled Substances Act of 1970. Richard Nixon and his ‘war on drugs’ didn’t care about loads of evidence showing all the medicinal uses of cannabis; he simply wanted marijuana banned. In fact, it was the National Commission on Marihuana and Drug Abuse that Nixon himself hired to prove the dangers of cannabis who ended up recommending cannabis instead be decriminalized based on the results of their findings. Unfortunately, the reasons for the banning of marijuana were not necessarily fair or logical, but here we are in 2019, and it is still a highly controlled substance.
Throughout the years, as marijuana has been up for rescheduling again and again, the Drug Enforcement Administration (DEA) continues to refuse regardless of studies showing marijuana’s numerous benefits. The DEA’s most recent refusal to reschedule marijuana happened in 2016. For the record, a Schedule I drug is one that has ‘no current accepted medicinal value in the United States.’ That’s where we’re at with marijuana currently, which seems ludicrous, especially considering that opioids have created an unprecedented crisis in the country for all the harm they cause. Still opioids are more useful than marijuana in the eyes of the government.
All this isn’t really news. We know the national government has long been ignoring the benefits of marijuana that countless studies have shown. What is curious, however, is that, despite keeping marijuana a Schedule I drug, the US Department of Health and Human Services (HHS) has a patent on certain parts of the marijuana plant. Patent no. 6,630,507 covers:
the potential use of non-psychoactive cannabinoids to protect the brain from damage or degeneration caused by certain diseases, such as cirrhosis.
The patent also covers cannabinoids that are useful in treating things like Alzheimer’s, Parkinson’s, and HIV dementia.
How can it be that the government keeps cannabis a Schedule I drug while at the same time having a patent on the plant for its medicinal uses? Is this utter hypocrisy, or are we missing something?
To be clear, the HHS does not have a patent on marijuana as a whole. The patent covers only parts of the plant, including the natural and synthetic non-psychoactive cannabinoids, including cannabidiol (CBD). CBD, as most cannabis-friendly folks know at this point, does not get anyone high. It is for this reason it seems there is some kind of loophole that has permitted patent no. 6,630,507 to go through.
How The US Government First Got a Patent on Cannabis
Back in 1999, three scientists from the National Institute of Mental Health (NIMH), Hampson, Axelrod, and Grimaldi, filed for patent no. 6,630,507. In 2003, the HHS gave them their patent. NIMH is part of the larger government agency, the National Institute on Drug Abuse (NIDA). NIDA is notorious for their anti-marijuana stance, publishing lots of studies that show marijuana is very bad.
Perhaps the fact that there are more than 20,000 studies that have shown marijuana’s positive medical effects is what led to NIDA granting this marijuana patent, especially since it only covers CBD, the non-psychoactive elements of the plant, for treating neurological conditions. Within the patent, it states the scientists discovered that there are antioxidant properties in CBD. It also states that any cannabinoid that acts through receptors such as THC is not covered. Still, issuing the patent in the first place seems to contradict marijuana being a Schedule I drug, seeing that the schedule itself is meant for substances that are dangerous and not useful for medical purposes in any way.
As time passes, cannabis research provides more and more peer-reviewed evidence that marijuana is effective in treating a vast array of medical issues, including cancer, glaucoma, multiple sclerosis, chronic pain, arthritis, asthma, insomnia, depression, and epilepsy. What’s more, it is also less expensive and less dangerous than many drugs currently used to treat many of these conditions. It makes sense that a patent for marijuana would be issued to create a better quality of life for people afflicted with any of these conditions. What does not make sense is why it is still a Schedule I drug.
Why Is Cannabis Still So Illegal Despite This Patent?
photo of recreational cannabis with container and label
Photo by LexScope on Unsplash
The National Institute of Health (NIH) hires about 6,000 Ph.D. scientists to oversee all the studies in its institutions. If a notable discovery is made, the decision must be made about whether to file a patent. Patent no. 6,630,507 was granted as a result of research showing the possibility that parts of the cannabis plant, those that are non-psychoactive, are effective in the treatment of neurological diseases. Because relief from these diseases via the cannabis plant is possible without getting high from THC, the patent was granted.
The patent does not say there is proof that treatment using cannabinoids is effective. That would require laboratory purification and synthesis of the compound, not to mention loads of animal and human testing, plus being approved by the FDA once all that is done, like what has happened with Epidiolex.
In other words, the patent was granted because–at the time it was applied-for–there was a possibility that it could be effective, and worthy of further research. In the meantime, the government has kept its potential largely hidden from the public and classified as a Schedule I drug.
Green in More Places Than One
That patent has a bit more complexity than just looking into the medical possibilities of certain parts of the cannabis plant, however. The government may have more than just public health in mind when this patent went through. There’s a lot of money to be made in the event that elements of the cannabis plant do provide effective medical treatments. In fact, the amount of money that certain firms could come into as a result of patent no. 6,630,507 is no small sum. This begs the question: who exactly is set to be making money off this deal?
Kannalife Sciences Inc. is a company based in New York. They obtained a license from the NIH in 2011 to use some of the patent’s technology. What they want to do is develop CBD-based medicines to treat hepatic encephalopathy (CTE), a form of brain damage. As such, Kannalife can now use the patented technology for research. In the event that they develop a successful drug, Kannalife CEO Dean Petkanas mentioned the government would get a huge percentage of sales that could result in six-figure royalties.
If the government has known about these potential benefits of parts of the cannabis plant, why did they deny the rescheduling of marijuana in 2016? Keeping marijuana a Schedule I drug makes it harder for other research to be done, which benefits Kannalife and the US government financially.
Before 2016, Kannalife was the only company with a license to a piece of the patent. That changed when GW Pharmaceuticals also got its own piece of the patent as it completed its new drug application for Epidolex. Epidolex is a drug developed using CBD to treat seizures. Upon approval, the drug could earn upwards of $2.2 billion a year. Seeing that the government will receive royalties from that as well, it raises questions about the real reasons marijuana has been kept a Schedule I drug.
With the legalization across many US states in recent years, companies have been both applying for and getting approved for patents using cannabinoids like CBD to make medicine for a variety of medical conditions. In 2018, the US Patent and Trademark Office issued 39 patents which contained the words marijuana or cannabis in their summaries. In 2017, that number was 29, and in 2016, only 14. Those patents are for different uses of cannabinoids than patent no. 6,630,507, though still completely leaving out THC.
Patent no. 6,630,507 expires on April 21, 2019. After that, using the cannabinoids outlined in the patent will be fair game for everyone, though any drugs created will still have to be approved by the FDA.
A Case of Hypocrisy
Even professionals like Gregory F. Wesner, a patent and trademark attorney, don’t deny the hypocrisy in patent no. 6,630,507. By classifying marijuana as a Schedule I drug, it means that all parts of the plant are deemed unsafe for consumption, according to the DEA and US government. Yet, the US government has a patent on synthetic cannabinoid drugs derived from marijuana, which are then being approved by the FDA.
Legalizing marijuana nationally would dramatically change the distribution of profits from marijuana, as many people and companies would be filing for patents almost immediately. The low number of patents approved per year despite abundant research showing the medical benefits of the plant serves to show how stifled the industry is by keeping marijuana a Schedule I drug. This begs the question: why does the US government continues to keep marijuana a Schedule I drug? Companies like Kannalife and GW Pharmaceuticals would be up against competition instead of having the industry nearly all to themselves, which would would cut into both their own profit and the profit the government. Companies like Kannalife and GW Pharmaceuticals would be up against competition instead of having the industry nearly all to themselves, which would would cut into both their own profit and the profit the government.
US Patent 6630507, Proudly powered by WordPress.
All in good fun…
Due diligence is mui important.
Next Up
NEXT UP
Hippy Jack raises $27,100 for Ukraine supports
Old traditions, new business
Chief Willie Sellars and cultural co-ordinator David Archie of the Williams Lake First Nation perform a tradition song Friday during a blessing ceremony at the WLFN’s new Unity Cannabis shop in Penticton.
Bonno/Penticton Herald
While most Indigenous communities in B.C. have embraced the grey market for cannabis, the Williams Lake First Nation has taken a different approach that embraces the law.
That decision has not paid off handsomely for the WLFN, with officials on Friday performing a cultural blessing at its Unity Cannabis shop in Penticton, which is the third such store it has opened in B.C.
Chief Willie Sellars, who attended the ceremony, said in an interview afterwards the decision to keep everything above board was grounded in economic and safety reasons.
“We wanted to have the ability to open a bank account legally. We wanted to make sure that the product on the shelves that the membership and community is going to be accessing is Health Canada-certified and safe, and we wanted to have the ability to ensure we take care of the people who are working in these stories,” said Sellars.
“We truly feel this is the future of the cannabis industry is the legal route. That being said, we also understand that the legal route is going to continue to evolve to make it more user-friendly and appealing to First Nations communities to go down this route.”
In the Okanagan, some First Nations communities have allowed cannabis shops to proliferate on their lands without licences from the B.C. government or channels to secure a legal supply of weed. There were more than 30 such outlets in the Southern Interior as of last fall, including six on Penticton Indian Band land alone.
As a result, grey-market bud is often much cheaper and much better than what’s found on the shelves at licensed shops like Unity Cannabis, which also has outlets in Williams Lake and Merritt.
By contrast, the WLFN in 2020 signed a unique government-to-government agreement with the province that allows it to operate eight retail stores – provided the shops are licensed and supplied with Health Canada-certified product – along with a production facility that will eventually offer farm-gate sales.
That 7,000-square-foot facility recently went into operation with a micro-cultivation licence under which it can produce 650 kilograms of bud annually, according to Sellars, who led extensive community consultation to secure a mandate to dive head-first into cannabis as a means to improve WLFN members’ lives and fund the restoration of language, culture and traditions.
“It’s going to take an investment, not only in cash but in time, and that’s exactly what we’re striving for,” said Sellars.
Not many customer showed up so far... another dud?
Crappy Growth is no Molson... lol
They are bankrupt.
Better start practissing now...
Best to wait when that dog is wortless... down to pennies.
Then go wild investing!
Just spreading cannabis knowledge to Ponzi suckers.
That train is RED and sinking fast!
I prefer the Legacy making money train...
Always on time like a Swiss train..
Lol.
Wearing rose colour glasses?
I,m watching a doomed Ponzi.
Ryan Lee
@ChimeraGenetics
Of all the changes the ????cannabis industry needs to survive, & we now get to buy 17 liters of beverages
People are losing their livelihoods, but can now buy 17 liters of products very few want
Progress is great but we need more than this- we need excise & distribution reform!
9:12 AM · Mar 12, 2022·Twitter for iPhone
1
Retweet
6
Likes
????WhatsMyPot??
@WhatsMyPot
·
1m
Replying to
@ChimeraGenetics
It's so painfully obvious who pushed for this specific change that only really affects a tiny fraction of the market ??
Pete Patterson, Spatial Cadet, ??R Dev
@OttawaPete
·
6m
Replying to
@ChimeraGenetics
I have yet to try any Cannabis infused beverage and probably never will.
Biggest marketing miss ever.
LP,s stock market weed prices dropping weekly.
Black & grey market raising prices monthly.
LP,s weed does,nt cut it with partaker.
Stock market weed is popular with non-partaker but.
https://www.cbc.ca/news/canada/montreal/supreme-court-constitutionality-quebec-cannabis-law-1.6380232
Quebecers don,t need permission to grow weed.
They are Canada biggest grey/black market growers.
DEA is the biggest black market drug dealer in the world.
Strangely enough...
Now we are talking some sense...
Give licences to the ones in the know.
Folks who are good at producing quality products.
https://www.cannabisculture.com/content/2022/03/09/new-yorkers-with-cannabis-convictions-will-get-first-retail-licenses/
Done matter.
Canadians are experience users.
They don,t need to be told...
They are experienced!
Have you ever been experienced?
I have!
What is the word Billy? The word is DOOMED!!!
https://mjbizdaily.com/cannabis-producer-canopy-growth-dropped-from-sp-tsx-60-index/
Sub-par products for a premium is not cutting it for Tilray.
Craft is doing A-OK but.
Grey market is pumping out 72 clone trays at 350$, pounds at 800$.
Bunk weed is doomed.
Give it a few months... This stock is going straight to hell.
Stock market weed prices are dropping weekly...
Supercritical (sc-CO2) extraction has been around for decades, appearing first in the 1980s as a cleaner and more viable alternative to other methods of separation and extraction.
Here<s a Dec 23, 2020 Tweet from Ryan Lee
Dec 23, 2020
Canopy Growth sues GW Pharmaceuticals:
Complaint for patent infringement filed on 12/22 in Texas
“This dispute relates to GW’s continued, unauthorized use of Canopy’s patented processes for extracting cannabidiol from cannabis plant material.”
$CGC $GWPH #cannabispatents
Ryan Lee
@ChimeraGenetics
GW related entities started filing patents in the late 90s
The GW extraction process cites a patent priority date of 1998/12/23 (22 years to today's date, exactly)
US 10/218972
GW worldwide extraction patent cites GB0218901.7 as priority
I'm not sure this will work out $CGC
12:48 AM · Dec 24, 2020
From the horse mouth:
" If your company grows cannabis & you think home growers are a threat to your business, GROW BETTER WEED
You’re a professional - be better than hobbyists. Restaurant owners, brewery owners, commercial farmers all make a living even with small scale self-producers making their own."
Ryan Lee
@ChimeraGenetics
I have to disagree...
LP,s burning billions is a function of ignorance.
Selling mediocre weed for a premium is not what customers want.
Top shelf FRESHcanna sells itself.
Buying Hexo is another fine dud.
Lol.
Smart companies scale their expansion to demand rather than build 1,000,000 sqft claiming they’ll produce for the entire world… Greenway doing things right - produce quality first, then expand to meet existing demand.
Ryan Lee
$5.83 for a pennie stock... Lol.
No wonder you are in the red.
Not knowing the canna market will burn your ass down big time. Lol
"I'm a legal grower in CA. Grew illegally for many years exactly like Bonno, and made the switch in '17. The system is absolutely fucked. ~70% tax rate (seed to sale), exorbitant licensing fees, land use requirements, unfair competition from the black market, etc etc. We've consistently harvested larger and larger canopies every season, and every year it gets harder to make ends meet. The annual black market flood came early this year and we literally had to shut down operations 2 months ahead of schedule and let 1000s of pounds rot in the field because we couldn't sell anything. Hard to compete with 400$ lbs when your cost of production isn't too far off from that..."
LP,s suffering the same fate in Canada...
When burning billions is the mood.
(selling canna) Lol.
Doomed.
THAT is your DD?
No need to.
We all know were this is going... Lol
Easy answer :
Better wait for .10 cents in my humble opinion... Lol
Another crappy growth law suit filed yesterday at New-York fed court
Where is Martha?
You will have to grow fire in the U.S.
Cause the black and Grey market is way bigger than in Canuk land.
LPs are doomed!
TILRAY TO THE MOON!!!
Cannabis users are health concious!!!
And they do not dring alcool either.
They dislike bunk.
I can clearly see your cannabis culture ignorance.